China’s Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27 billion in HK listing
By Scott Murdoch (Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is aiming to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong listing, according to a regulatory filing made on Thursday. The deal will be the second in Hong Kong to raise above $1 billion in the past week, as the …
China’s Jiangsu Hengrui Pharmaceuticals aims to raise up to $1.27 billion in HK listing Read More »








